Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21070402)

  • 1. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
    Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
    Int J Exp Pathol; 2011 Apr; 92(2):97-105. PubMed ID: 21070402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.
    Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
    Virchows Arch; 2010 Apr; 456(4):403-9. PubMed ID: 20300773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells.
    Cao Y; Merling A; Karsten U; Goletz S; Punzel M; Kraft R; Butschak G; Schwartz-Albiez R
    Int J Cancer; 2008 Jul; 123(1):89-99. PubMed ID: 18398838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
    Lingala S; Cui YY; Chen X; Ruebner BH; Qian XF; Zern MA; Wu J
    Exp Mol Pathol; 2010 Aug; 89(1):27-35. PubMed ID: 20511115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549.
    Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ
    Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers.
    Hou Y; Zou Q; Ge R; Shen F; Wang Y
    Cell Res; 2012 Jan; 22(1):259-72. PubMed ID: 21862973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors.
    Dragon AC; Beermann LM; Umland M; Bonifacius A; Malinconico C; Ruhl L; Kehler P; Gellert J; Weiß L; Mayer-Hain S; Zimmermann K; Riese S; Thol F; Beutel G; Maecker-Kolhoff B; Yamamoto F; Blasczyk R; Schambach A; Hust M; Hudecek M; Eiz-Vesper B
    Front Immunol; 2023; 14():1219165. PubMed ID: 37915564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
    Choi D; Lee HW; Hur KY; Kim JJ; Park GS; Jang SH; Song YS; Jang KS; Paik SS
    World J Gastroenterol; 2009 May; 15(18):2258-64. PubMed ID: 19437567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.
    Zhan XX; Zhao B; Diao C; Cao Y; Cheng RC
    Endocr Pathol; 2015 Mar; 26(1):21-6. PubMed ID: 25614211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.